Mucinex Sinus-max Solution
Product Images NDC 63824-129

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mucinex Sinus-max (NDC 63824-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reckitt Benckiser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back Label (72854 212 Label Back)

Drug Facts panels for Mucinex Rapid Clear Pain, Headache, and Mucus Congestion and Clear & Cool Nasal Spray components of the kit. The panels list active ingredients oxymetazoline hydrochloride 0.05% as nasal decongestant in the nasal spray, and acetaminophen 325 mg with guaifenesin 200 mg per capsule as pain reliever/fever reducer and expectorant. Both include detailed uses, warnings, directions, inactive ingredients, and contact information.*

FDA Label Image

Carton Label (72854 212 Label Front)

Mucinex Rapid Clear Pain, Headache & Mucus Congestion and Mucinex Sinus Max Clear & Cool kit. The packaging highlights acetaminophen and guaifenesin for pain relief, fever reduction, and mucus thinning in 16 liquid gel capsules. It also includes a 3/4 fl oz nasal spray with 0.05% oxymetazoline hydrochloride for severe nasal congestion relief, featuring fast-acting, 12-hour duration, and cooling menthol flavor. Labeler: Reckitt Benckiser LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.